Showing results (1521-1530 of 1,619) with videos related to
Sort By:
Pageof 162
Journal of the National Cancer Institute|March 14, 2014
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomicsLois B Travis, Sophie D Fossa, Howard D Sesso, et al.Investigational New Drugs|May 25, 2021
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumorsRyan Ashkar, Darren R Feldman, Nabil Adra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell TumorsDarren R Feldman, James Hu, Tanya B Dorff, et al.The Oncologist|February 15, 2021
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell TumorsSamuel A Funt, Deaglan J McHugh, Stephanie Tsai, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 28, 2019
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasisRichard G B Langley, Kristian Reich, Vibeke Strand, et al.Annals of Surgery|January 25, 2020
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell TumorsRaul Caso, Gregory D Jones, Manjit S Bains, et al.Clinical Genitourinary Cancer|June 1, 2017
Genomic Characterization of Renal Medullary Carcinoma and Treatment OutcomesMaria I Carlo, Joshua Chaim, Sujata Patil, et al.Journal of Computer Assisted Tomography|March 31, 2010
Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trialSteven S Raman, Christopher Leary, David A Bluemke, et al.Ear and Hearing|January 24, 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric AssessmentsShirin Ardeshirrouhanifard, Sophie D Fossa, Robert Huddart, et al.Journal of the National Cancer Institute|February 3, 2025
Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancerSarah L Kerns, Paul C Dinh, Patrick O Monahan, et al.Pageof 162